UCB's Global Corporate Website

EADV 2021: Shining a light on the latest science in dermatology

Picture of author Natalie Nunez Gomez
Posted by
Natalie Nunez Gomez, Global Medical Affairs Psoriasis

At UCB, we believe that collaborating with physicians, researchers and patients is fundamental to addressing the unmet needs of people living with immuno-dermatological diseases, such as psoriasis. We recognize that there is potential to improve the lives of people with psoriasis and we’re looking forward to discussing the latest scientific advancements in this field with the dermatology community at the virtual European Academy of Dermatology and Venereology (EADV) Congress, taking place from 29 September - 2 October 2021. Now in its 30th year, the EADV Congress 2021 will bring together leading clinical experts across the fields of dermatology and venereology in a celebration of outstanding data and scientific exchange.

At this year’s EADV Congress, we will be sharing the latest findings from our ongoing research in dermatology across 13 e-posters and one platform presentation. Attending healthcare professionals will also be able to virtually join five UCB-sponsored educational meetings, including our satellite symposium, and hear about the newest approaches and advances in psoriasis care from world-leading experts in dermatology. Following the congress close, delegates will also have virtual access to these meetings and sessions up until the end of the year.

We are proud to be sponsors of this year’s EADV Congress. Platforms such as EADV 2021, which allow us to further our understanding of immuno-dermatological diseases like psoriasis remain as important as ever – particularly when we consider the impact these conditions continue to have on the lives of patients. Psoriasis affects approximately 125 million people worldwide and is a life-long condition, for which there is no cure. Much more than ‘just a skin condition’, psoriasis has been shown to have a profoundly detrimental impact on a person’s quality of life. UCB’s approach – from discovery to development to delivery – is designed around patient needs and their journey, we therefore remain determined to better understand the impact of immuno-dermatological conditions such as psoriasis, to help find solutions that allow patients to live life to the fullest.

EADV 2021 promises to be an outstanding educational learning experience with stimulating sessions, late-breaking science and an opportunity to connect with experts in dermato-venereology. We’re ready to shine a light on how we are advancing care for people living with psoriasis and to be inspired by other groundbreaking work from our colleagues in the dermatology community. If you are a healthcare professional attending EADV 2021, we look forward to welcoming you to the UCB virtual booth and at our educational sessions.

You can stay informed about UCB news at EADV 2021 through our social media channels (Twitter, LinkedIn).

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.

9 + 5 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.